Skip to content

Persistent Coronavirus Challenges in Almaty Continue

In the current scenario, the megacity reports a total of 20,635 confirmed cases of coronavirus infection.

Persistent Challenges Persist in Almaty Due to Coronavirus Outbreak
Persistent Challenges Persist in Almaty Due to Coronavirus Outbreak

Persistent Coronavirus Challenges in Almaty Continue

In Almaty, Kazakhstan, the daily infection growth rate remains steady at 0.5%, as of the latest available data. This figure represents a slight decrease compared to the national average of 1.1.

As of the last reported data, there are 20,635 confirmed cases of COVID-19 in Almaty, with 112 patients currently admitted to infectious hospitals. Of these, 84 are symptomatic, and 28 are asymptomatic.

The age distribution of cases in Almaty shows that 34.7% of cases are in the 20-39-year age group, 28.7% are in the 40-59-year age group, and 21.3% are 60 years and above. Notably, 20 cases are children.

While in a critical condition, 17 patients are being closely monitored in hospitals, with 147 in serious condition and 644 in a mild condition. A total of 82 patients have been successfully discharged from hospitals.

Mayor B. Sagintayev recently reminded citizens of the importance of adhering to sanitary and epidemiological safety measures. During a broadcast, he answered questions about various city issues, including road construction and repair, gas supply, support for people with disabilities, and the development of megacity infrastructure.

It is essential to note that the most recent COVID-19-related publications from the region focus on vaccination pharmacovigilance in Uzbekistan, not Kazakhstan, and do not mention infection rates or hospitalization trends in Almaty. For the most accurate and up-to-date information, consult official sources such as the Kazakhstani Ministry of Health or local public health authorities.

The main routes of infection in Almaty from January 3 to 19 were identified as public places (40.1%), contact with a COVID-positive family member (27.4%), public transport (22.8%), contact with a COVID-positive colleague (5.6%), and import from abroad and other regions (2.6%).

[1] Vaccination Pharmacovigilance in Uzbekistan: A Case Study [2] Post–COVID-19 Vaccination Rates and Complications in Various Regions [3] World Bank: Kazakhstan COVID-19 Response and Recovery [4] United Nations: Kazakhstan's COVID-19 Response and Recovery Plan 2021-2022

Amidst the ongoing health crisis in Almaty, Kazakhstan, there is a growing need for comprehensive research in the field of medical-conditions, particularly those related to COVID-19. Actionable insights from science, such as the main routes of infection and the age distribution of cases, are crucial for implementing health-and-wellness strategies tailored to the local population.

Read also:

    Latest